Schizophrenia Research
Volume 92, Issue 1 , Pages 74-84 , May 2007

Iowa Gambling Task in schizophrenia: A review and new data in patients with schizophrenia and co-occurring cannabis use disorders

  • Serge Sevy

      Affiliations

    • Department of Psychiatry Research, Zucker Hillside Hospital, North-Shore-Long Island Jewish Health System, 75-59 263rd Street, Glen Oaks, NY, 11004, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 718 470 8175; fax: +1 718 343 1659.
    • ,
  • Katherine E. Burdick

      Affiliations

    • Department of Psychiatry Research, Zucker Hillside Hospital, North-Shore-Long Island Jewish Health System, 75-59 263rd Street, Glen Oaks, NY, 11004, USA
    • ,
  • Hema Visweswaraiah

      Affiliations

    • Department of Psychiatry Research, Zucker Hillside Hospital, North-Shore-Long Island Jewish Health System, 75-59 263rd Street, Glen Oaks, NY, 11004, USA
    • ,
  • Sherif Abdelmessih

      Affiliations

    • Department of Psychiatry Research, Zucker Hillside Hospital, North-Shore-Long Island Jewish Health System, 75-59 263rd Street, Glen Oaks, NY, 11004, USA
    • ,
  • Meredith Lukin

      Affiliations

    • Department of Psychiatry Research, Zucker Hillside Hospital, North-Shore-Long Island Jewish Health System, 75-59 263rd Street, Glen Oaks, NY, 11004, USA
    • ,
  • Eldad Yechiam

      Affiliations

    • Department of Industrial Engineering and Management — Technion Israel Institute of Technology, Haifa, 32000, Israel
    • ,
  • Antoine Bechara

      Affiliations

    • Department of Neurology, Division of Cognitive Neuroscience, University of Iowa College of Medicine, Iowa City, IA, USA

Received 6 September 2006 ,Revised 11 January 2007 ,Accepted 19 January 2007.

References 

  1. Addington J, Addington D. Substance abuse and cognitive functioning in schizophrenia. J. Psychiatry Neurosci. 1997;22:99–104
  2. Allen DN, Goldstein G, Aldarondo F. Neurocognitive dysfunction in patients diagnosed with schizophrenia and alcoholism. Neuropsychology. 1999;13:62–68
  3. Arndt SA, Tyrrell G, Flaum M, Andreasen NC. Comorbidity of substance abuse and schizophrenia. The role of pre-morbid adjustment. Psychol. Med. 1992;22:379–388
  4. Bechara A. Decision-making, impulse control, and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005;8:1458–1463
  5. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7–15
  6. Bechara A, Damasio H, Tranel D, Damasio AR. Deciding advantageously before knowing the advantageous strategy. Science. 1997;275:1293–1295
  7. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia. 2001;39:376–389
  8. Beninger RJ, Wasserman J, Zanibbi K, Charbonneau D, Mangels J, Beninger BV. Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation. Schizophr. Res. 2003;61:281–292
  9. Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C, et al. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. NeuroImage. 2003;19:1085–1094
  10. Bolla KI, Eldreth DA, Matochik JA, Cadet JL. Neural substrates of faulty decision-making in abstinent marijuana users. NeuroImage. 2005;26:480–492
  11. Bowie CR, Serper MR, Riggio S, Harvey PD. Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients. Schizophr. Bull. 2005;31:175–182
  12. Busemeyer JR, Stout JC. A contribution of cognitive decision models to clinical assessment. Decomposing performance on the Bechara gambling task. Psychol. Assess. 2002;14:253–262
  13. Cavallaro R, Cavedini P, Mistretta P, Bassi T, Angelone SM, Ubbiali A, et al. Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study. Biol. Psychiatry. 2003;54:437–443
  14. Cleghorn JM, Kaplan MD, Szechtman B, Szechtman H, Brown GM, Franco S. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J. Clin. Psychiatry. 1991;52:26–30
  15. Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res. 1988;26:223–238
  16. Cornblatt BA, Lenzenweger MF, Erlenmeyer-Kimling L. The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Res. 1989;29:65–85
  17. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia. 2002;40:2257–2267
  18. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test: Adult Version San AntonioTX, The Psychological Corporation. 1987;
  19. Evans CEY, Bowman CH, Turnbull OH. Subjective awareness on the Iowa Gambling Task. The key role of emotional experience in schizophrenia. J. Clin. Exp. Neuropsychol. 2005;27:656–664
  20. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1998. Structured Clinical Interview for Axis I DSM-IV Disorders- Patient Edition, New York: Biometrics Research Department, New York State Psychiatric Institute.
  21. First, M.B., Spitzer, R.L., Gibbon, M., et al. 2001. Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Non-patient Edition, New York: Biometrics Research Department, New York State Psychiatric Institute.
  22. George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, et al. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology. 2002;26:75–85
  23. Gijsman HJ, Scarnà A, Harmer CJ, McTavish SFB, Odontiadis J, Cowen PJ, et al. A dose-finding study on the effects of branch Chain amino acids on surrogate markers of brain dopamine function. Psychopharmacology. 2002;160:192–197
  24. Grant S, Contoreggi C, London ED. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia. 2000;38:1180–1187
  25. Harmer CJ, McTavish SFB, Clark L, Goodwin GM, Cowen PJ. Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology. 2001;154:105–111
  26. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry. 2005;162:1403–1413
  27. Kester HM, Sevy S, Yechiam E, Burdick K, Cervellione KL, Kumra S. Decision-making impairments in adolescents with early-onset schizophrenia. Schizophr. Res. 2006;85:113–123
  28. Lee C, Frangou S, Russel MA, Gray JA. Effect of haloperidol on nicotine-induced enhancement of vigilance in human subjects. J. Psychopharmacol. 1997;11:253–257
  29. Mazas CA, Finn PR, Steinmetz JE. Decision-making biases, antisocial personality, and early-onset alcoholism. Neurobiol., Psychosoc., Dev. Correl. Drink. 2000;24:1036–1040
  30. Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend. 2002;67:41–51
  31. Murray RM, Grech A, Phillips P, Johnson S. In:  Murray RM,  Jones PB,  Susser E,  van Os J,  Cannon M editor. What is the Relationship Between Substance Abuse and Schizophrenia. UK: Cambridge University Press; 2003;p. 317–342
  32. Nixon SJ, Hallford HG, Tivis RD. Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients. Psychiatry Res. 1996;64:35–45
  33. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004;72:29–39
  34. Pencer A, Addington J. Substance use and cognition in early psychosis. J. Psychiatry Neurosci. 2003;28:48–54
  35. Petry NM, Bickel WK, Arnett M. Shortened time horizons and insensitivity to future consequences in heroin addicts. Addiction. 1998;93:729–738
  36. Reitan RM. Manual for Administration of Neuropsychological Test Batteries for Adults and Children. Tuscon, AZ: Reitan Neuropsychological Laboratory; 1979;
  37. Ritter LM, Meador-Woodruff JH, Dalack GW. Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia. Schizophr. Res. 2004;68:65–73
  38. Rodríguez-Sánchez JM, Crespo-Facorro B, Iglesias RP, Bosch CGB, Álvarez M, Llorca J, et al. Prefrontal cognitive functions in stabilized first-episode patients with schizophrenia spectrum disorders: a dissociation between dorsolateral and orbitofrontal functioning. Schizophr. Res. 2005;77:279–288
  39. Serper MR, Bergman A, Copersino ML, Chou J-CY. Learning and memory impairment in cocaine dependent and comorbid schizophrenic patients. Psychiatry Res. 2000;93:387–394
  40. Sevy S, Kay SR, Opler L, van Praag HM. Significance of cocaine history in schizophrenia. J. Nerv. Ment. Dis. 1990;178:642–648
  41. Sevy S, Robinson DR, Holloway S, Alvir JM, Woerner MG, Bilder R, et al. Correlates of substance abuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr. Scand. 2001;104:367–374
  42. Sevy S, Hassoun Y, Bechara A, Yechiam E, Napolitano B, Burdick K, et al. Emotion-based decision-making in healthy subjects: short-term effects of reducing dopamine levels. Psychopharmacology. 2006;188:228–235
  43. Shurman B, Horan WP, Nuechterlein KH. Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task. Schizophr. Res. 2005;72:215–224
  44. Spreen O, Strauss E. A Compendium of Neurological Tests: Administration, Norms, and Commentary. 2nd ed.. New York: Oxford University Press; 1998;
  45. Stirling J, Lewis S, Hopkins R, White C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr. Res. 2005;75:135–137
  46. Thurnbull OH, Evans CEY, Kemish K, Park S, Bowman CH. A novel set-shifting modification of the Iowa Gambling Task: flexible emotion-based learning in schizophrenia. Neuropsychology. 2006;3:290–298
  47. Tremeau F. A review of emotion deficits in schizophrenia. Dialogues Clin. Neurosci. 2006;8:59–70
  48. Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry. 2004;9:557–569
  49. Whitlow CT, Liguori A, Livengood LB, Hart SL, Mussat-Whitlow BJ, Lamborn CM, et al. Long-term heavy marijuana users make costly decisions on a gambling task. Drug Alcohol Depend. 2004;76:107–111
  50. Wilder KE, Weinberger DR, Goldberg TE. Operant conditioning and the orbitofrontal cortex in schizophrenic patients: unexpected evidence for intact functioning. Schizophr. Res. 1998;30:169–174
  51. Williamson P. In: Mind, Brain, and Schizophrenia. New York: Oxford University Press; 2006;p. 65–74
  52. Yechiam E, Busemeyer JR, Stout JC, Bechara A. Using cognitive models to map relations between neuropsychological disorders and human decision-making deficits. Psychol. Sci. 2005;16:973–978

PII: S0920-9964(07)00055-2

doi: 10.1016/j.schres.2007.01.005

Schizophrenia Research
Volume 92, Issue 1 , Pages 74-84 , May 2007

Article Tools

* Image Usage & Resolution